A total of 118 recommendations based on expert consensus were published regarding the treatment of hidradenitis suppurativa in 7 specific patient populations.
Treatment depends on how deep the melanoma is and whether it has spread. This is called the stage of the cancer. Treatment also depends on your general health and where the melanoma is on your body.
Recurrent implantation failure (RIF ... there is still no widely accepted definition or standard protocol for the diagnosis and treatment of RIF. Progress in predicting and preventing RIF has been ...
Growing evidences suggest a place of IL-1 receptor antagonists in the treatment of recurrent pericarditis. Many retrospective studies, one recent randomised placebo-controlled study and data of a real ...
Notably, mounting evidence in recent years revealed that FMT has made a breakthrough in the oncology treatment area, especially by improving immunotherapy efficacy to achieve antitumor effects.
Recurrent aphthous ulcer (RAU ... anti-inflammatory and anti-allergic agent that has been evaluated for the treatment of RAU in a series of robust clinical trials. After a 100mg dose of 5% ...
Learn about VE303, a potential first-in-class Live Biotherapeutic Product for preventing recurrent Clostridioides difficile infection (rCDI).
Prior to the announcement of the winners on 1st October, we look at Astellas' Clostridium difficile therapy Dificlir ... of Astellas Pharma's C. diff treatment Dificlir (fidaxomicin) for the ...
This indicator covers the incidence of healthcare associated infections from Clostridium difficile (C. diff). It measures outcomes that reflect the quality of care or processes linked by evidence to ...
FDA approved to prevent recurrent C. difficile infection (rCDI ... Home to help patients with rCDI across the U.S. receive treatment at home as well as health care settings Ferring continues ...
for the prevention of recurrent C. difficile (C. diff) infection in individuals 18 years of age and older, following antibiotic treatment for C. diff infection. Launched on January 23, 2023 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results